Identification the Cause of Silent Cerebral infarctiON in Healthy Subjects (ICONS)
NCT ID: NCT01429948
Last Updated: 2011-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
581 participants
OBSERVATIONAL
2008-04-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
NCT03268668
Long-term Prognosis in Stroke Patients
NCT03510312
Arterial Wall Shear Stress After Intracranial Artery Recanalization
NCT06290271
Prevention and Treatment of Reperfusion Injury After Mechanical Thrombectomy in Acute Ischemic Stroke
NCT05282290
Assessment of Coronary Artery Disease in Stroke Patients
NCT01850693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case group
Healthy subjects with silent cerebral infarction
No interventions assigned to this group
Control group 1
Patients with acute cryptogenic embolic stroke
No interventions assigned to this group
Control group 2
Patients with acute stroke with conventional stroke mechanisms
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with age over 20 years
* Subjects who consecutively visited a health promotion center for a health screening examination that included routine laboratory test, cardiac work-ups (12-lead electrocardiography and/or echocardiography), and brain magnetic resonance image (MRI) and MR angiography (MRA)
* Subjects who showed silent brain infarction (SCI) which was defined as a focal hyperintensity lesion 3 mm or large in diameter in the fluid-attenuation inversion recovery (FLAIR) images without a history of a corresponding stroke or transient ischemic attack (TIA)
* Subjects who performed agitated saline transcranial Doppler (TCD) monitoring
Patients with acute stroke (both cryptogenic embolic stroke and conventional stroke mechanisms)
* Patients with age over 20 year
* Patients with focal neurologic deficits presented within 7 days of symptom onset
* Patients with acute ischemic lesions on diffusion-weighted image (DWI)
* Patients who performed agitated saline TCD monitoring
Exclusion Criteria
* Subjects with the presence of previous history of stroke or TIA
* Subjects with the presence of dementia on history taking or mini-mental status examination
* Subjects with the presence of proximal source of embolism, including atrial fibrillation or significant (≥50%) stenosis on cervicocerebral artery on MRA or carotid Duplex
* Subjects who had SCI restricted within perforator territory (basal ganglia or pons) suggesting that microangiopathy rather than embolism could be the main mechanism of SCI
* Subjects in whom agitated saline TCD monitoring was not performed or those who had poor temporal windows
Patients with acute stroke (both cryptogenic embolic stroke and conventional stroke mechanisms)
* Patients in whom agitated saline TCD monitoring was not performed or those who had poor temporal windows
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oh Young Bang, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center, Sungkyunkwan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center, Sungkyunkwan University
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim SJ, Shin HY, Ha YS, Kim JW, Kang KW, Na DL, Bang OY. Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the Cause of Silent Cerebral Infarction in Healthy Subjects). Eur J Neurol. 2013 Feb;20(2):353-60. doi: 10.1111/j.1468-1331.2012.03864.x. Epub 2012 Sep 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-02-046
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.